发明名称 |
NMR MEASUREMENTS OF GLYCA |
摘要 |
Biomarkers and/or risk assessments identify patients having an increased risk of certain clinical disease states including, for example, CHD, type 2 diabetes, dementia, or all-cause death (ACD) using NMR signal to measure a level of “GlycA” in arbitrary units or in defined units (e.g., μmol/L) that can be determined using a defined single peak region of proton NMR spectra. The GlycA measurement can be used as an inflammation biomarker for clinical disease states. The NMR signal for GlycA can include a fitting region of signal between about 2.080 ppm and 1.845 ppm of the proton NMR spectra. |
申请公布号 |
SG11201407803T(A) |
申请公布日期 |
2014.12.30 |
申请号 |
SGT11201407803 |
申请日期 |
2013.05.30 |
申请人 |
LIPOSCIENCE, INC. |
发明人 |
OTVOS, JAMES D.;SHALAUROVA, IRINA Y.;BENNETT, DENNIS W.;WOLAK-DINSMORE, JUSTYNA E. |
分类号 |
G01N24/08;A61B5/055;G01N33/49 |
主分类号 |
G01N24/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|